Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07355387 · ClinicalTrials.gov registry record · NA

Home Based Functional Balance Intervention for Multiple Sclerosis

A NA study of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT07355387: Recruiting NA study of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting, sponsored by University of Illinois at Chicago.

NCT07355387 is a NA study of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 75 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07355387, a NA study of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on physical and cognitive function, as well as measures of daily living among persons with multiple sclerosis (PwMS). Combined Specific Aims: Aim 1: Examine the effect of the FBI (Intervention Group) on physical function in PwMS compared to a stretching program (Control Group). Hypothesis 1: After four months of training, the FBI group will show significantly greater improvements in physical function compared to the stretching group. Aim 2: Examine the effect of the multicomponent FBI on cognitive function in PwMS compared to the stretching program. Hypothesis 2: After four months of training, the FBI group will show significantly greater improvements in cognitive function compared to the stretching group. Aim 3: Examine the effects of the multicomponent FBI compared to the Control Group among PwMS on measures of daily living (dual-task performance, balance confidence, community mobility, and quality of life). Hypothesis 3: After four months of training, the FBI group will show significantly greater improvements in measures of daily living compared to the stretching group. All assessment sessions will be conducted virtually via Zoom. All measures collected during the initial screening, pre-training assessment, training progression, and mid- and post-training assessment sessions will be administered either via Zoom with a Helper Buddy present or through survey links sent to participants via the UIC REDCap system. The training sessions will be performed independently by the participants in the presence of a Helper Buddy. The investigators will recruit 75 people with multiple sclerosis (PwMS) for this study. Eligible participants will be randomized to either the FBI (Intervention) or stretching (Control) group, followed by an onboarding session with a designated Helper Buddy. Training will occu

Primary Outcome

Non-serious adverse events may include transient muscle soreness, fatigue, mild dizziness, temporary loss of balance corrected by the helper buddy, or minor joint discomfort during home exercise. These events do not require medical intervention and are reported during weekly check ins or directly to study staff. Serious adverse events include any event resulting in injury requiring medical care, hospitalization, life-threatening symptoms, severe cardiovascular responses (chest pain, uncontrolle

Interventions

  • BEHAVIORAL Stretching
  • BEHAVIORAL Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance.

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-11-24
Est. Completion 2027-11-24
Phase NA
University of Illinois at Chicago

430 total trials

What NCT07355387 shows while recruiting

NCT07355387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower).

The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Stretching is the first listed.

NCT07355387 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07355387 about?

NCT07355387 is a clinical study titled "Home Based Functional Balance Intervention for Multiple Sclerosis". The study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on physical and cognitive function, as well as measures of daily living among persons with multiple sclerosis (PwMS). Combined Spe...

What is the current status of trial NCT07355387?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-11-24. Estimated completion is 2027-11-24.

What conditions does trial NCT07355387 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis (MS) Secondary Progressive, Multiple Sclerosis Acute and Progressive.

What interventions are being tested in trial NCT07355387?

The interventions under investigation include: Stretching (BEHAVIORAL), Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance. (BEHAVIORAL).

Who is sponsoring clinical trial NCT07355387?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07355387 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07355387's enrollment target sits among peer trials

75 147th of 315 higher than 167 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07355387, the US trial registry maintained by the National Library of Medicine. NCT07355387 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.